SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 63,904 Value ($000) $2,093 Avg Close $26.13 Range $15.86 - $35.31
Q1 2025
Shares 130,884 Value ($000) $2,112 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 1,079,307 Value ($000) $25,126 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 707,586 Value ($000) $20,810 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 707,586 Value ($000) $16,635 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 707,590 Value ($000) $26,839 Avg Close $28.97 Range $18.54 - $47.97
Q4 2023
Shares 576,711 Value ($000) $12,411 Avg Close $13.78 Range $8.43 - $22.66
Q3 2023
Shares 97,053 Value ($000) $1,189 Avg Close $13.22 Range $9.53 - $18.00